Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C3orf62 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | HS3ST4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | C17orf75 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RPAP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C7orf26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DDX18 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RUSC2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | LIG3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KCNH7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NR2C1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |